长非编码RNAFOXP4-AS1在人类癌症中的新兴作用:从分子生物学到临床应用
Jingjie Yang1,2
1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, 443002, China.
Heliyon
|November 14, 2024
概括
叉头盒P4反感RNA1 (FOXP4-AS1),一个长的非编码RNA,在癌症中起着复杂的作用,既作为瘤抑制剂,又作为瘤基因. 它的失调会影响癌症的进展和患者的预后,强调其作为治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 叉头盒P4反感RNA1 (FOXP4-AS1) 是一个长的非编码RNA (lncRNA),位于染色体6p21.1.1.
- 在各种癌症中,FOXP4-AS1的调节失调,表现为瘤抑制剂或瘤基因的双重作用.
- 它的表达水平与临床癌症特征和患者预后相关.
研究的目的:
- 审查FOXP4-AS1瘤学研究的最新进展.
- 概述癌症中FOXP4-AS1的分子调节网络.
- 讨论FOXP4-AS1作为治疗标和生物标记物的潜力.
主要方法:
- 在癌症研究中对FOXP4-AS1的文献综述.
- 分子机制的分析,包括miRNA海绵和通路激活.
- 检查FOXP4-AS1在调节癌症表型中的作用.
主要成果:
- FOXP4-AS1受转录因子ATF3,YY1,PAX5和SP4.4的调节.
- 它通过miRNA海绵,调节宿主基因FOXP4,并激活信号通路 (PI3K/AKT,Wnt/β-catenin,ERK/MAPK) 来影响癌症.
- FOXP4-AS1影响瘤的扩散,入侵,上皮细胞-介质细胞过渡 (EMT) 和血管生成.
结论:
- FOXP4-AS1是癌症发展和进展的关键参与者.
- 了解其复杂的分子机制对于治疗开发至关重要.
- 作为瘤学的诊断和预后生物标志物,FOXP4-AS1显示出前途.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K


